KDM1A and small cell lung carcinoma: A preclinical study conducted by Nguyen et al. illustrated that inhibition of lysine-specific demethylase 1 (LSD1) could restore cell surface expression of MHC-I, activate antigen presentation pathways, and enhance anti-tumor response to ICIs in SCLC [98].